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Background. The diagnosis of cerebral malaria is problematic in malaria-endemic areas because encephalopa-
thy in patients with parasitemia may have another cause. Abnormal retinal ﬁndings are thought to increase the spe-
ciﬁcity of the diagnosis, and the level of histidine-rich protein 2 (HRP2) may reﬂect the parasite biomass.
Methods. We examined the retina and measured plasma HRP2 levels in children with acute nontraumatic en-
cephalopathy in Kenya. Logistic regression, with HRP2 level as an independent variable and World Health Organi-
zation–deﬁned cerebral malaria and/or retinopathy as the outcome, was used to calculate malaria-attributable
fractions (MAFs) and retinopathy-attributable fractions (RAFs).
Results. Of 270 children, 140 (52%) had peripheral parasitemia, 80 (30%) had malaria retinopathy, and 164
(61%) had an HRP2 level of >0 U/mL. During 2006–2011, the incidence of HRP2 positivity among admitted chil-
dren declined by 49 cases per 100 000 per year (a 78% reduction). An HRP2 level of >0 U/mL had a MAF of 93%
for cerebral malaria, with a MAF of 97% observed for HRP2 levels of ≥10 U/mL (the level of the best combined sen-
sitivity and speciﬁcity). HRP2 levels of >0 U/mL had a RAF of 77% for features of retinopathy combined, with the
highest RAFs for macular whitening (99%), peripheral whitening (98%), and hemorrhages (90%).
Conclusion. HRP2 has a high attributable fraction for features of malarial retinopathy, supporting its use in the
diagnosis of cerebral malaria. HRP2 thresholds improve the speciﬁcity of the deﬁnition.
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Cerebral malaria is the most severe neurological com-
plication of falciparum malaria and is associated with
signiﬁcant morbidity and mortality [1]. The World
Health Organization (WHO) deﬁnes cerebral malaria
as unarousable coma (Blantyre coma score of ≤2 or in-
ability to localize a painful stimulus) in a child with
asexual malaria parasites in the peripheral blood and
exclusion of other causes of encephalopathy [2]. In
most malaria-endemic areas, this deﬁnition is problem-
atic for 2 reasons. First, the prevalence of parasitemia in
asymptomatic children in the community can be as
high as 70%, and thus a child admitted with coma from
any cause may have coincidental parasitemia [3]. This
proportion of children with asymptomatic parasitemia
increases with an increase in transmission intensity of
malaria and vice versa [4]. Second, the exclusion of po-
tential causes of childhood nontraumatic coma requires
an extensive battery of tests, including virologic and
neuroimaging analyses, most of which are not available
in hospitals in malaria-endemic areas. These problems
with the deﬁnition of malaria can affect interventions
such as vaccines and treatment studies [5].
The pathognomonic feature of pathological cerebral
malaria is sequestration of parasite-infected erythrocytes
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in the cerebral microvasculature. Taylor et al found that 23% of
Malawian children who died after fulﬁlling WHO-deﬁned crite-
ria for cerebral malaria antemortem did not have sequestered
parasite-infected erythrocytes [6]. They found that malaria reti-
nopathy (ie, retinal whitening [macular and peripheral], vessel
color changes, and retinal hemorrhages with or without papille-
dema) was strongly associated with parasite-infected erythro-
cytes sequestered in the brain [7]. The retinal ﬁndings may
reﬂect those in the brain since the retina and the cerebral cortex
are embryologically, anatomically, and physiologically related
[8]. Although such ﬁndings are based on small numbers of chil-
dren who died, they demonstrated that malaria retinopathy can
be used in evaluating the diagnostic usefulness of other clinical
laboratory features in sequestration-deﬁned cerebral malaria.
There is a need to identify other clinical and laboratory measures
to distinguish cerebral malaria from other encephalopathies
because autopsy studies reﬂect the situation in the fatal cases
only and may not be representative of children who survive and
because peripheral parasitemia may not reﬂect the parasites se-
questered in the brain [1].
Histidine-rich protein 2 (HRP2) is secreted by Plasmodium
falciparum throughout its 48-hour cycle and remains intraery-
throcytic until mature schizonts release it into blood [9]. It is
thought to reﬂect the parasitemia biomass and to have diagnos-
tic and prognostic value in malaria [10, 11]. However, the diag-
nostic value of HRP2 in cerebral malaria has not been validated.
Recently, Hendriksen et al used a mechanistic model to show
that HRP2 reliably identiﬁed those with increased risk for coma
[12, 13], but they did not evaluate the diagnostic value of HRP2
levels in patients with retinopathy. Only 1 study attempted to
validate HRP2 against malarial retinopathy by using receiver
operating characteristic (ROC) curve statistics, and it found
that HRP2 accounted for 90% of the area under the ROC curve
[14]. However, ROC curve statistics are less sensitive than likeli-
hood tests and are less likely to distinguish the relative contri-
bution of many risk factors affecting an outcome [15].
Logistic regression techniques that use maximum likelihood
analysis [16] can be used to compute the malaria-attributable
fraction (MAF) for WHO-deﬁned cerebral malaria and the
retinal attributable fraction (RAF) for cerebral malaria, using
the HRP2 level as a marker of sequestered biomass. Attribut-
able fractions are considered predictive estimates of the number
of children who would not be admitted with cerebral malaria if
malaria were eliminated. Logistic regression techniques com-
pute attributable fractions by comparing HRP2 levels in chil-
dren admitted with WHO-deﬁned cerebral malaria and/or
retinopathy (the case group) to that of children admitted with-
out these features (the comparison group) [17]. Logistic regres-
sion uses the distribution of HRP2 levels to compute attributable
fractions that are both sensitive and speciﬁc, as opposed to the
dichotomous presence or absence of HRP2, which would be
biased toward sensitivity [17]. We recently used a similar
method to deﬁne and estimate the proportion of seizures attrib-
utable to falciparum malaria in a malaria-endemic area on the
Kenyan coast [18].
We used a logistic model to determine the diagnostic value
of HRP2 levels by computing attributable fractions for WHO-
deﬁned cerebral malaria and features of retinopathy. We further
examined whether the incidence of HRP2 positivity among ad-
mitted children declined during a period when the incidence of
malaria decreased on the Kenyan coast.
METHODS
Patients and Study Area
This study was conducted in Kiliﬁ District Hospital (KDH) in a
malaria-endemic area on the Kenyan coast. KDH is the main
district-level hospital in the area and draws its admissions pre-
dominantly from the local residents, who are from the Mijiken-
da community. The hospital morbidity surveillance is directly
linked with a population framework referred to as the Kiliﬁ
Health Demographic Surveillance System (KHDSS) [19]. This
area has seen a signiﬁcant reduction in hospital admissions
with malaria and parasite prevalence in the community [20],
both of which are good surrogate measures for a changing
malaria transmission intensity. The hospital has a 35-bed pedi-
atric ward and an 8-patient high-dependency unit that mainly
admit children with malaria and bacterial infections [19]. The
present analysis is part of larger ongoing study that is investi-
gating the pathophysiology of severe malaria under the auspice
of the Severe Malaria in African Children network [21]. Study
participants were all children admitted with coma (deﬁned as a
Blantyre coma score of ≤2 or the inability to localize a painful
stimuli) [22] between July 2005 and December 2011. These
children were given appropriate emergency care and treatments
according to the national guidelines by clinicians and nurses at
the hospital, who provide 24-hour clinical cover.
Clinical and Laboratory Procedures
We prospectively collected standardized clinical, laboratory,
and anthropometric data for this study. Clinicians were trained
in an indirect ophthalmoscopy by an experienced ophthalmol-
ogist. They performed ophthalmoscopy on all children older
than 9 months who presented with encephalopathy, deﬁned as
inability to localize a painful stimulus [23]. The signs of malari-
al retinopathy can be identiﬁed in unconscious children by
trained clinicians using indirect fundoscopy, which has a sensi-
tivity of 95% [24]. Pupils were dilated with tropicamide 0.5% or
1% eye drops, with the addition of 2.5% phenylephrine if re-
quired. The 2 clinicians (E. C. and M. K.) who conducted most
(80%) of the examinations had a substantial agreement for the
features of retinopathy (κ = 0.70). Complete blood counts were
performed using an automated system (Beckman/Counter),
and blood gas concentration was determined by the IL 1620
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analyzer (Instrument Laboratories). Falciparum malaria parasi-
temia was counted on thick and thin blood slides stained with
10% Giemsa.
Determination of HRP2 Levels
An enzyme-linked immunosorbent assay (ELISA) was used to
determine the presence of HRP2 in frozen plasma samples,
which had been stored at −80°C for 1–7 years. High-adsorbing
plates (Maxisorp NUNC-Immuno plate) were coated with 100
µL/well of 1.0 µg/mL immunoglobulin M monoclonal anti-
HRP2 antibody (MPFM-55A, Immunology Consultants Labo-
ratories, Newberg, OR), diluted in phosphate-buffered saline
(PBS), and incubated overnight at 4°C. One hundred microli-
ters of diluted plasma samples (1:64) were added to the plates,
and plates were sealed and incubated at room temperature in a
humid chamber for 2 hours and then washed 5 times. One
hundred microliters of secondary antibody conjugated with
horseradish peroxidase (MPFG-55P, Immunology Consultants
Laboratories; 0.2 μg/mL diluted in 2% bovine serum albumin,
1% Tween 20, and PBS) was added to the wells and incubated
in a humid chamber for another 1 hour at room temperature.
Substrate (SigmaFast OPD P9187-50SET) was then added, in-
cubation was performed for 30 minutes at room temperature,
and the reaction was stopped by adding 50 µL of 2 N sulfuric
acid to each well. The plates were read using a plate reader at an
OD of 490. The standards were made by serially diluting
plasma samples of known parasitemia, with the highest parasi-
temia at 0.2% and the lowest at 0.003125% (this gave a 0.1 ab-
sorbance value above the negative absorbance). HRP2 levels are
speciﬁed in arbitrary units per milliliter (U/mL) of plasma,
because no recombinant protein was used.
Deﬁnition of Terms
Cerebral malaria was deﬁned as unarousable coma in a child ad-
mitted with slide-positive falciparum malaria and whose coma
did not resolve 30 minutes after cessation of seizures or cor-
rection of electrolyte imbalances or hypoglycemia [25]. The reti-
nopathy deﬁnition included hemorrhages, peripheral whitening,
macular whitening, papilledema, or vessel color changes [24].
Respiratory distress was deﬁned as deep Kussmaul-type breath-
ing. Epilepsy was deﬁned as history of 2 unprovoked seizures,
meningitis was deﬁned as a cerebrospinal ﬂuid white blood cell
count of >50 cells/µL, sepsis was deﬁned as evidence of inﬂam-
mation and microbial process, and undetermined encephalopa-
thy was deﬁned as coma whose cause could not be established.
Malnutrition was deﬁned as a height-for-age z score of ≤2,
severe anemia was deﬁned as a hemoglobin concentration of
<50 g/L, hypoglycemia was deﬁned as a blood glucose concen-
tration of <3 mmol/L, and hyponatremia was deﬁned as a
sodium concentration of <135 mEq/L. Acidosis was deﬁned as a
base excess value of ≤8. Parasitemia was determined by standard
methods [26]. On admission, clinicians enquired about premor-
bid conditions.
Statistical Analysis
All analyses were performed using Stata (version 11, Stata
Corp, College Station, TX). The Mann-Whitney U test was
used to compare age between retinopathy-positive admissions
and retinopathy-negative admissions. Pearson χ2 test was used
to compare categorical variables between groups. The z scores
for malnutrition were computed using a Stata command
zanthro (2000 CDC Growth Reference, USA). Only the ﬁrst
hospital admission with HRP-positive coma was considered in
the incidence analysis. The incidence was calculated for chil-
dren who lived in the KHDSS, using the estimated midyear
population count of children as the denominator. A decline in
the incidence of these admissions was estimated as the diffe-
rence between mean incidence for the ﬁrst 2 years of the study
and the mean incidence for the last 2 years of the study.
Logistic regression methods were used to model the risk of
WHO-deﬁned cerebral malaria and/or retinopathy as a contin-
uous function of HRP2 level in these children [17]. Absolute
HRP2 levels in children with WHO-deﬁned cerebral malaria
and/or retinopathy and from a comparison group of children
without these conditions were used to model the relationship
between HRP2 levels and cerebral malaria and/or retinopathy.
We used the logistic regression model log[p/1–p] =[ a + bxt],
where p is the probability that a child with HRP2 at density x
has cerebral malaria/malarial retinopathy, and t is the power
function that stabilizes the maximum likelihood estimation. The
coefﬁcient b was then used to calculate the MAF for WHO-
deﬁned cerebral malaria and the RAF for sequestration-deﬁned
cerebral malaria for each child, ﬁrst at any HRP2 level and then
at different HRP2 thresholds. The risks of a group with cerebral
malaria and/or retinopathy were averaged to estimate the pro-
portion of the group whose encephalopathy is caused by
malaria rather than by another illness with coincidental HRP2.
The averaged risks gave the MAF for WHO-deﬁned cerebral
malaria or the RAF for sequestration-deﬁned cerebral malaria
for the group analyzed [16], as deﬁned by HRP2. Sensitivity and
speciﬁcity were then calculated using the MAF for retinopathy
or the proportion of cases with retinopathy within each level of
HRP2. This logistic regression analysis was repeated for speciﬁc
features of retinopathy. Conﬁdence intervals (CIs) around the
MAF were estimated by bootstrapping with 500 iterations. The
logistic model was adjusted for age (categorized into those older
and those younger than 5 years, a cutoff age when immunity to
severe malaria develops [27]) and year (as a surrogate measure
of changing transmission intensity of malaria). A P value of
≤.05 was considered statistically signiﬁcant.
Permission to conduct this study was granted by the Kenyan
Medical Research Institute National Ethics Committee (Scien-
tiﬁc Steering Committee no. 1249).
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RESULTS
Indirect fundoscopy was performed in 270 children admitted
with acute encephalopathy to KDH. Of the children who met
the WHO deﬁnition for cerebral malaria, 164 (60.7%) were
positive for HRP2 in plasma, and 140 (51.9%) had peripheral
parasitemia (Figure 1). At least 1 feature of retinopathy was ob-
served in 80 of 270 study participants (29.6%). Of the 270 study
participants, 147 (54.4%) were males. The median age was 39.0
months (interquartile range, 25.0–55.0 months) and was signif-
icantly higher among slide-positive admitted children than
slide-negative admitted children, but there was no difference
between retinopathy-positive and retinopathy-negative admit-
ted children (Table 1).
Clinical and Laboratory Characteristics Associated With
Encephalopathy
Results of comparisons between children who were positive
and those who were negative for parasitemia and/or retinopa-
thy are shown in Table 1. The median HRP2 level was signiﬁ-
cantly greater among children with than among those without
slide-positive encephalopathy (P < .0001) and signiﬁcantly
greater among children with than among those without reti-
nopathy (P < .0001; Figure 2 and Table 1). Thrombocytopenia
was more common among children with than among those
without slide-positive encephalopathy (P < .0001) and more
common among children with than among those without reti-
nopathy (P = .001). Malnutrition was less common among
slide-positive admitted children than among slide-negative ad-
mitted children (P < .0001). Additionally, previous hospitaliza-
tion during the perinatal period was less common among
children with than among those without retinopathy (P = .028).
The median levels of HRP2 were higher among children with
retinopathy than among those without retinopathy for all fea-
tures except vessel color changes (Table 2).
Retinopathy Among Admitted Children With Encephalopathy
Of the 270 children who had indirect fundoscopic examination
performed, 80 (29.6%) had at least 1 feature of retinopathy:
hemorrhages were observed in 41 (51·3%), papilledema in 24
(30.0%), macular whitening in 21 (26.3%), vessel color changes
in 18 (22.5%), and peripheral whitening in 15 (18.8%; Table 2).
MAFs and RAFs for Admitted Children With Encephalopathy
HRP2 levels of >0 U/mL had a MAF of 92.9% (95% CI, 83.9%–
97.8%) for WHO-deﬁned cerebral malaria; the MAF was 96.0%
(95% CI, 89.5–99.2) for ≥3 U/mL, the threshold with the best
combined sensitivity and speciﬁcity (Figures 2 and 3). Use of
higher HRP2 thresholds further reduced the sensitivity of the
case deﬁnition.
HRP2 levels of >0 U/mL had a RAF of 76.7% (95% CI,
52.1%–90.9%) for at least 1 feature of retinopathy; the RAF in-
creased to 83.6% (95% CI, 59.3%–95.1%) for levels of ≥5 U/
mL, the threshold for the maximum combined sensitivity and
speciﬁcity. Higher levels of HRP2 reduced the sensitivity.
For macular whitening, HRP2 levels of >0 U/mL had a RAF
of 98.8% (95% CI, 87.2%–100.0%); levels of ≥5 U/mL had a
RAF of 99.8% (95% CI, 92.7%–100.0%) and the best combined
sensitivity and speciﬁcity (Table 3). For peripheral whitening,
HRP2 levels of >0 U/mL had a RAF of 97.7% (95% CI, 71.1%–
100.0%); levels of ≥5 U/mL had a RAF of 99.4% (95%
CI, 79.6%–100.0%) and the best combined sensitivity and spe-
ciﬁcity. For hemorrhages, HRP2 levels of >0 U/mL had a RAF
Figure 1. Flowchart of slide-positive, histidine-rich protein 2 (HRP2) positivity and retinopathy positivity among children admitted with encephalopathy.
Parasitemia and malaria retinopathy were examined on the day of admission, whereas assays of HRP2 were done in the last year of the study.
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Table 1. Clinical and Laboratory Characteristics of Admissions With Acute Nontraumatic Encephalopathy
Characteristic
Parasitemia Status Retinopathy Status
Positive Negative
Statistic or
Score P Positive Negative
Statistic or
Score P
Age, mo 41 (29–53) 35 (16–57) z=−2.21 .0275 40 (29–56) 39 (21–54) z=−1.06 .2898
Male sex 72/138 (52.2) 75/127 (59.1) χ2 = 1.27 .260 46/79 (58.2) 101/186 (54.3) χ2 = 0.35 .5560
Delivered at hospital 8/124 (6.5) 13/110 (11.8) χ2 = 2.06 .1520 9/71 (12.7) 12/163 (7.4) χ2 = 1.71 .1910
Head circumference 48.6 (47.0–50.0) 48.0 (45.1–49.7) z=−1.73 .0831 48.0 (46.3–49.5) 48.0 (46.0–50.0) χ2 = 0.104 .9175
Jaundice 6/125 (4.8) 6/120 (5.0) χ2 = 0.01 .9420 6/75 (8.0) 6/170 (3.5) χ2 = 2.23 .1350
Perinatal hospitalization 3/99 (3.0) 6/92 (6.5) χ2 = 1.29 .255 0/63 (0.0) 9/128 (7.0) χ2 = 4.65 .0310
Prematurity 3/99 (3.0) 2/93 (2.2) χ2 = 0.15 .702 5/124 (4.0) 0/64 (1.2) χ2 = 2.65 .1030
Birth problems 16/140 (11.4) 11/130 (8.5) χ2 = 0.66 .417 9/80 (11.3) 18/190 (9.5) χ2 = 0.197 .6570
Malnutrition 42/120 (35.0) 64/105 (61.0) χ2 = 15.14 <.0001 30/70 (43.9) 76/155 (49.0) χ2 = 0.74 .3390
Respiratory distress 26/137 (19.0) 35/127 (27.6) χ2 = 2.73 .098 14/79 (17.7) 47/185 (25.4) χ2 = 1.84 .1750
Febrile temperatures 113/124 (91.3) 100/120 (83.3) χ2 = 3.34 .068 70/75 (93.3) 143/169 (84.6) χ2 = 3.56 .0590
Seizures 110/123 (89.4) 92/100 (92.0) χ2 = 0.43 .5140 59/65 (90.8) 143/158 (90.5) χ2 = 0.01 .9510
Severe anemia 14/111 (12.6) 4/80 (5.0) χ2 = 3.16 .076 8/53 (15.1) 10/138 (7.3) χ2 = 2.8 .0960
Acidosis 55/102 (53.9) 29/65 (44.6) χ2 = 1.38 .241 24/44 (54.6) 60/123 (48.8) χ2 = 0.43 .5120
Leukocytosis 52/140 (37.1) 45/129 (34.9) χ2 = 0.15 .700 31 (38.8) 66/189 (34.9) χ2 = 0.36 .5550
Thrombocytopenia 76/111 (68.5) 6/80 (7.5) χ2 = 70.54 <.0001 34/56 (60.7) 48/135 (35.6) χ2 = 10.23 .0010
Hypoglycemia 14/140 (10.0) 9/130 (6.9) χ2 = 0.82 .3650 10/80 (12.5) 13/190 (6.8) χ2 = 2.31 .1280
Hyponatremia 46/97 (47.4) 36/77 (46.8) χ2 = 0.01 .930 22/52 (42.3) 60/122 (49.2) χ2 = 0.69 0.401
HRP2 level 19 764 (2872–28 802) 27 (0–283) z=−7.25 <.0001 26 969 (3223–31 523) 578 (4.5–18 799) z=−4.74 <.0001
Geometric mean parasitemia (95% CI) 32 095 (1898–54 259) . . . . . . 2031 (8761–47 053) 27 830 (14 928–51 883) t= 0.42 .6764
Died 21/140 (15.0) 39/130 (30.0) χ2 = 8.78 .003 21/80 (26.3) 39/190 (20.5) χ2 = 1.07 .3020
Data are proportion (%) of patients or median level (interquartile range), unless otherwise indicated. See Methods for definitions.
Abbreviations: CI, confidence interval; Hb, hemoglobin; HRP2, histidine-rich protein 2; WBC, white blood cell.
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of 90.1% (95% CI, 67.2%–98.5%); levels of ≥5 U/mL had a RAF
of 94.6% (95% CI, 74.5%–99.6%) and the best combined sensi-
tivity and speciﬁcity. HRP2 levels had a low RAF for papillede-
ma and vessel color changes (Table 3).
Frequency of Other Potential Causes of Coma, by HRP2
Thresholds
The following alternative causes of coma were more common
among children with HRP2 levels below the modeled thresh-
olds (ie, 10 U/mL), compared with children with greater HRP2
levels, for WHO-deﬁned cerebral malaria: meningitis, 19 of 22
(86.3%) versus 2 of 22 (13.7%); undetermined encephalopathy,
37 of 49 (75.5%) versus 12 of 39 (24.5%); epilepsy, 3 of 5
(60.0%) versus 2 of 5 (40.0%); and sepsis, 2 of 3 (66.7%) versus
1 of 3 (33.3%).
Decline in the Incidence of HRP2-Positive Acute
Encephalopathy
The incidence of HRP2-positive encephalopathy among admit-
ted children decreased by 78%, from 63 cases per 100 000 per
year in 2006 and 2007 to 14 cases per 100 000 per year in 2010
and 2011 (Figure 4). This was slightly smaller than the modeled
MAF of 93% for WHO-deﬁned cerebral malaria at HRP2 levels
of >0 U/mL.
DISCUSSION
This study demonstrates that plasma HRP2 levels in children
with encephalopathy improve the speciﬁcity of the diagnosis of
cerebral malaria, as further supported by very high RAFs for
Figure 2. The median and distribution of histidine-rich protein 2 (HRP2) levels among admitted children with acute encephalopathy, by malaria and/or reti-
nopathy status, and the sensitivities and speciﬁcities associated with HRP2 levels among admitted children with World Health Organization–deﬁned cerebral
malaria. The median levels of HRP2 were signiﬁcantly higher among children with than among those without a slide positive for malaria parasites, and levels
were higher among children with than among those without retinopathy. Sensitivities worsened with higher levels of HRP2, whereas speciﬁcities improved.
Table 2. Retinopathy Status of Study Participants and Associated
Median Histidine-Rich Protein 2 Levels
Feature
Retinopathy-
Positive
Participants
Retinopathy-
Negative
Participants
PaNo.
HRP2 Level,
Median
(IQR) No.
HRP2 Level,
Median
(IQR)
At least 1 sign
of retinopathy
80 27 (3–32) 190 0.6 (0.005–19) <.0001
Hemorrhages 41 29 (22–34) 190 0.6 (0.005–19) <.0001
Macular
whitening
21 31 (28–34) 190 0.6 (0.005–19) <.0001
Papilledema 24 31 (1–36) 190 0.6 (0.005–19) .0129
Peripheral
whitening
15 30 (23–32) 190 0.6 (0.005–19) .0001
Vessel color
changes
18 14 (0–30) 190 0.6 (0.005–19) .3640
Abbreviation: IQR, interquartile range.
a For the median difference in HRP2 level between the retinopathy-positive and
retinopathy-negative groups. The retinopathy features are not mutually exclusive.
HRP2 levels are arbitrary units per microlitre of plasma.
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hemorrhages and macular and peripheral whitening, the fea-
tures of retinopathy-deﬁned cerebral malaria. The usefulness of
the HRP2 level in the diagnoses of malaria would be further
improved by using a plasma level that offers a balance between
sensitivity and speciﬁcity and the exclusion of alternative
causes of coma. These conclusions are supported by the pro-
portional decline in the incidence of HRP2 positivity among
admitted children over the study period comparable to
modeled MAFs and RAFs.
The median HRP2 levels among admitted children with
coma were signiﬁcantly higher for those who were positive for
parasitemia and retinopathy than for those who were negative,
supporting the hypotheses that parasite biomass is related to
cerebral malaria. Additionally, children who were negative for
retinopathy were more likely to have been previously hospital-
ized with perinatal complications, compared with children who
were positive, suggesting that retinopathy is more related to
malaria than other causes, as documented in Malawi [28].
Thrombocytopenia was more common among children with
than among children without cerebral malaria and/or retinopa-
thy, which is consistent with previous ﬁndings for severe
malaria [29].
The high MAFs for WHO-deﬁned cerebral malaria are com-
parable to those reported by another study [12], supporting the
diagnostic role of HRP2. The computed MAF for WHO-
deﬁned cerebral malaria was comparable to the observed
decline of HRP2 positivity among admitted children with en-
cephalopathy over a period when the burden of malaria was
reduced, although the observed decline was slightly smaller. At-
tributable fractions can be inﬂuenced by factors related to ac-
quisition of immunity, such as age and transmission intensity
of malaria [16]. In particular, low transmission intensity is as-
sociated with high MAF or RAF [17], but we attempted to
account for this effect by including year of study and age into
the logistic model. The smaller observed decline in the inci-
dence of HRP2 positivity among admitted children may be as-
cribed to the increasing ratio of cerebral malaria to severe
malaria anemia as the transmission intensity for malaria de-
creases [20].
The high RAF as explained by HRP2 level, albeit for all fea-
tures of retinopathy (including those clinically known to be less
speciﬁc to malaria) [24], further highlights the diagnostic value
of the HRP2 level in cerebral malaria. Features of retinopathy
speciﬁc to malaria may reﬂect a subgroup of cerebral malaria
involving sequestration, as was demonstrated in an autopsy
study [6].
HRP2 levels of >0 U/mL were associated with the highest
RAF for retinal whitening (99% for macular whitening, 98% for
peripheral whitening, and 90% for hemorrhages 90%). The
RAF increased to almost 100% for macular and peripheral
whitening and to 95% for the hemorrhages at an HRP2 level of
5 U/mL, which is a balance between both sensitivity and
Figure 3. Sensitivity and speciﬁcity of malaria-attributable fractions for children admitted with encephalopathy, by histidine-rich protein 2 (HRP2) level.
MAFs were ﬁrst determined at HRP2 levels of >0 U/mL and then at HRP2 levels with the best combined sensitivity and speciﬁcity.
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speciﬁcity. Retinal whitening may be more speciﬁc to malaria,
since it is rarely seen in other childhood illnesses [30]. It is
thought to be a result of oncotic swelling of neurons in the
inner retina due to metabolic or hypoxic stress that occurs in
cerebral malaria [24, 25].
At any level of HRP2, the RAF for hemorrhages was high
(90%) but was expected to be lower than that for retinal whiten-
ing, since hemorrhages may be caused by other conditions,
such as severe anemia [31]. The low RAF for vessel color
changes at any HRP2 level is surprisingly low, since this feature
would be expected to be more speciﬁc than hemorrhages to
malaria [24]. Vessel color changes may have been missed on ex-
amination, which could have reduced the RAF [32]. In particu-
lar, incorrect judgment of retinal signs by the examiner (eg,
choroidal vessels being mistaken for the abnormal vessels of ce-
rebral malaria) may also explain the low RAF for vessel color
changes. In Ghanaian and Malian studies [30, 33], vessel color
changes were not common among children with cerebral
malaria, suggesting regional differences in this sign [24].
These HRP2-determined attributable fractions computed in
this study have implication in design of intervention trials for ce-
rebral malaria. For example, the AQUAMAT study found that
artesunate reduced mortality by 22.5%, compared with quinine
[34], and this was based on correct use of a dichotomous pres-
ence or absence of lactate dehydrogenase, which may be as spe-
ciﬁc as HRP2. If the deﬁnition of cerebral malaria in this study
relied on the presence of parasitemia only (which has a MAF of
85% [17], compared with 93% for HRP2 in this study), the rela-
tive mortality would have been underestimated as 20.5%.
The proportion of healthy community children with malarial
retinopathy is not known, since it is technically difﬁcult toTa
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Figure 4. The declining incidence of histidine-rich protein 2 (HRP2) pos-
itivity among children admitted with coma during a period when the
malaria incidence had declined. The incidence was calculated for children
who lived in the Kiliﬁ Health Demographic Surveillance System, using the
annual midyear populations of children as the denominators.
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perform indirect fundoscopy on conscious children, so we
assumed that retinopathy in our study subjects was related to
the hospital admission. The attributable fractions modeled are
based on HRP2 data assessed with an ELISA that may not be
100% sensitive, and the long duration of storage of some
samples may have affected the validity. Furthermore, the levels
of HRP2 may have been affected for children who were treated
with antimalarials in periphery facilities, which can further
complicate modeling of attributable fractions.
This study conﬁrms that the HRP2 level can reliably be used
to distinguish cerebral malaria from other acute encephalopa-
thies, since it was associated with high attributable fractions for
cerebral malaria and/or retinopathy (particularly, retinal whit-
ening and hemorrhages). Further inclusion of HRP2 thresholds
and exclusion of alternative causes of coma would improve the
speciﬁcity of the deﬁnition of cerebral malaria in intervention
studies. The study also conﬁrms that papilledema is not speciﬁc
to malaria and that assessment of vessel color changes may
require an experienced clinician, but there may be regional dif-
ferences in this sign. These ﬁndings need to be replicated in
other areas before the HRP2 level can be universally accepted
for the diagnosis of cerebral malaria.
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